Author

Dong Liu

Institution: Genfleet Therapeutics (Shanghai) Inc. (China)

Observed institutions: National Medical Products Administration, Hebei General Hospital, Changchun Institute of Biological Products, Hebei University of Chinese Medicine, National Institutes for Food and Drug Control, Liaoning Cancer Hospital & Institute, Genfleet Therapeutics (Shanghai) Inc. (China)

ORCID: 0000-0002-5198-1799

Observed ORCID: 0000-0002-5198-1799

OpenAlex ID: A5101485117

Fructus gardeniae ameliorates anxiety-like behaviors induced by sleep deprivation via regulating hippocampal metabolomics and gut microbiota

2023 · Dong Liu, Qianfei Wang, et al. · Frontiers in Cellular and Infection Microbiology · 34

Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer

2012 · Kai-Yu Han, Xin Gu, et al. · Tumor Biology · 25

Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors

2023 · Bopei Cui, Lifang Song, et al. · Signal Transduction and Targeted Therapy · 24

First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors

2024 · Ye Guo, Zishu Wang, et al. · BMC Cancer · 22

Tumor Regression Grade Predicts Survival in Locally Advanced Gastric Adenocarcinoma Patients with Lymph Node Metastasis

2020 · Yilin Tong, Yanmei Zhu, et al. · Gastroenterology Research and Practice · 8

Clinicopathologic analysis of 41 cases of small cell lung carcinoma

2010 · Dong Liu · China Modern Medicine

Works count: 6

Citation count: 113

H-index: 5

I10-index: 4